The Clinical Core provides an important and integral component of CFAR, bringing basic science and rational drug design and development with human volunteer studies. The Clinical Core has three facility components of importance; there are two clinical research environments (the UAB-AIDS Ambulatory Care Clinic and the UAB General Clinical Research Center) and the Clinical Laboratory Core (see description of facilities). In these environments, volunteers will be evaluated prospectively on pharmacokinetics, therapeutics and in vivo pathogenesis studies. Data management and retrieval as well as specimen storage will be standardized for CFAR investigators. Clinical studies will be performed with Institutional Review Board approval.
The Specific Aims for this Clinical Core are: 1. To provide a mechanism for CFAR investigators to obtain specimens (tissue, cells, body fluids, etc.) from consenting volunteers who are evaluated serially and prospectively for basic research studies. 2. To maintain resources of determining drug pharmacokinetics, including metabolism, disposition, clearance and modeling. 3. To make available all identification facilities for evaluation of a consenting patient by CFAR investigators. 4. To develop the Clinical setting for performance of drug evaluations of locally developed therapeutics as well as national therapeutic priorities including Phase I pharmacokinetics and Phase II, III controlled trials for consenting volunteers. 5. To provide contemporary biostatistical resources for data management, data retrieval, pharmacokinetic modeling and study design. 6. To develop novel approaches for allowing translation of developments in the drug targeting core and vaccine development.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027767-02
Application #
3814978
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Rice, Whitney S; Logie, Carmen H; Napoles, Tessa M et al. (2018) Perceptions of intersectional stigma among diverse women living with HIV in the United States. Soc Sci Med 208:9-17
Elion, Richard A; Althoff, Keri N; Zhang, Jinbing et al. (2018) Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr 78:62-72
Fredericksen, R J; Gibbons, L; Brown, S et al. (2018) Medication understanding among patients living with multiple chronic conditions: Implications for patient-reported measures of adherence. Res Social Adm Pharm 14:540-544
Stoll, Matthew L; Weiss, Pamela F; Weiss, Jennifer E et al. (2018) Age and fecal microbial strain-specific differences in patients with spondyloarthritis. Arthritis Res Ther 20:14
Subramaniam, Akila; Van Der Pol, William J; Ptacek, Travis et al. (2018) Midtrimester microbial DNA variations in maternal serum of women who experience spontaneous preterm birth. J Matern Fetal Neonatal Med :1-9
Kay, Emma S; Rice, Whitney S; Crockett, Kaylee B et al. (2018) Experienced HIV-Related Stigma in Health Care and Community Settings: Mediated Associations With Psychosocial and Health Outcomes. J Acquir Immune Defic Syndr 77:257-263
Xu, Wanli; Luo, Zhenwu; Alekseyenko, Alexander V et al. (2018) Distinct systemic microbiome and microbial translocation are associated with plasma level of anti-CD4 autoantibody in HIV infection. Sci Rep 8:12863
Smith, Samuel R; Schaaf, Kaitlyn; Rajabalee, Nusrah et al. (2018) The phosphatase PPM1A controls monocyte-to-macrophage differentiation. Sci Rep 8:902
Wang, Yong; Schafer, Cara C; Hough, Kenneth P et al. (2018) Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5. J Immunol 201:278-295
Jones, Robert B; Dorsett, Kaitlyn A; Hjelmeland, Anita B et al. (2018) The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1? signaling. J Biol Chem 293:5659-5667

Showing the most recent 10 out of 955 publications